The Carnival Horizon was named by godmother Queen Latifah in a ceremony in New York on Wednesday evening that also showcased the talented young artists from St. Jude Children’s Research Hospital whose artwork adorns the Dreamscape, a stunning three-deck-high LED sculpture in the ship’s atrium.
“Carnival Horizon’s naming ceremony was one of our best yet, with Queen Latifah carrying out her duties as godmother then battling it out with Super Bowl champion Jake Elliott of my hometown Philadelphia Eagles in an entertaining Lip Sync Battle,” said Christine Duffy, president of Carnival Cruise Line. “We were also delighted to showcase the wonderfully talented children from St. Jude whose artwork on the Dreamscape will be forever associated with this spectacular ship.”
Added Latifah, “My time aboard Carnival Horizon was nothing short of incredible. In addition to having the honour of serving as the ship’s godmother, meeting the amazing kids from St. Jude and their families and squaring off against Jake in an all-out Lip Sync Battle is certainly something I will always cherish.”
Following the ceremony, Latifah squared off against Philadelphia Eagles Super Bowl champion Jake Elliott in Lip Sync Battle: Horizon modelled after the hit Paramount Network TV series and rolling out across the Carnival fleet.
St. Jude Children’s Research Hospital received a $100,000 donation from Carnival representing monies raised from various fundraisers, both onboard and ashore. The funds continue the line’s ongoing support of St. Jude with more than $16 million raised in the fight against childhood cancer since the partnership began in 2010.
“This is an absolute thrill for our patients and their families to have their artwork featured as a permanent display on this magnificent ship,” said Richard Shadyac Jr., president and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital. “The ongoing support of Carnival team members and their customers around the globe for our lifesaving mission plays a critical role in advancing research and treatment for pediatric cancer and other life-threatening diseases.”